← RXO, Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Net income (loss) | $43.0m |
$150.0m
+248.84%
|
$92.0m
-38.67%
|
$4.0m
-95.65%
|
($290.0m)
-7350.00%
|
($100.0m)
+65.52%
|
— | |
| Depreciation and amortization expense | $76.0m | $81.0m | $86.0m | $67.0m | $87.0m | $116.0m | $106.0m | |
| Deferred tax benefit | ($9.0m) | $3.0m | ($20.0m) | ($8.0m) | ($19.0m) | ($21.0m) | — | |
| Stock compensation expense | $8.0m | $8.0m | $32.0m | $19.0m | $23.0m | $29.0m | — | |
| Payment for tax withholdings related to vesting of stock compensation awards | $0 | $0 | ($3.0m) | ($14.0m) | ($4.0m) | ($19.0m) | — | |
| Accrued tax withholdings related to vesting of stock compensation awards | — | — | $0 | $0 | $15.0m | $0 | — | |
| Impairment of operating lease assets | — | — | $0 | $0 | $13.0m | $4.0m | — | |
| Goodwill impairment | — | — | — | $0 | $0 | $12.0m | $14.0m | |
| Accounts receivable | ($264.0m) | ($242.0m) | $92.0m | $158.0m | ($109.0m) | ($5.0m) | ($387.0m) | |
| Accounts payable | $87.0m | $129.0m | ($14.0m) | ($86.0m) | ($65.0m) | ($16.0m) | $256.0m | |
| Purchases of property and equipment in accounts payable, accrued expenses and other liabilities | — | — | $4.0m | $2.0m | $3.0m | $11.0m | ($59.0m) | |
| Accrued expenses, other current liabilities and other long-term liabilities | $75.0m | $27.0m | $22.0m | ($60.0m) | $117.0m | $2.0m | — | |
| Other | $0 | $1.0m | ($1.0m) | ($2.0m) | $11.0m | ($10.0m) | — | |
| Other current assets and other long-term assets | ($5.0m) | ($4.0m) | $14.0m | ($14.0m) | $8.0m | $19.0m | — | |
| Net cash provided by (used in) operating activities | $25.0m |
$155.0m
+520.00%
|
$310.0m
+100.00%
|
$89.0m
-71.29%
|
($12.0m)
-113.48%
|
$51.0m
+525.00%
|
($17.0m)
-133.33%
|
|
| Payment for purchases of property and equipment | ($47.0m) | ($39.0m) | ($57.0m) | ($64.0m) | ($45.0m) | ($59.0m) | — | |
| Proceeds from sale of property and equipment | $8.0m | $1.0m | $1.0m | $0 | $0 | $2.0m | — | |
| Net cash used in investing activities | ($39.0m) | ($38.0m) | ($56.0m) | ($66.0m) | ($1.1b) | ($71.0m) | ($57.0m) | |
| Proceeds from borrowings on revolving credit facilities | — | $0 | $0 | $76.0m | $238.0m | $566.0m | — | |
| Repayment of borrowings on revolving credit facilities | — | $0 | $0 | ($71.0m) | ($226.0m) | ($533.0m) | — | |
| Repayment of debt and finance leases | — | $0 | $0 | ($104.0m) | ($3.0m) | ($2.0m) | ($1.3b) | |
| Payment for debt issuance costs | $0 | $0 | ($9.0m) | $0 | ($3.0m) | $0 | — | |
| Proceeds from issuance of common stock and pre-funded warrants | — | — | $0 | $0 | $1.1b | $0 | $0 | |
| Repurchase of common stock | — | $0 | $0 | ($2.0m) | $0 | $0 | — | |
| Net cash provided by (used in) financing activities | $32.0m |
($158.0m)
-593.75%
|
($183.0m)
-15.82%
|
($117.0m)
+36.07%
|
$1.1b
+1047.01%
|
$1.0m
-99.91%
|
$71.0m
+7000.00%
|
|
| Net increase (decrease) in cash, cash equivalents and restricted cash | $19.0m | ($41.0m) | $69.0m | ($93.0m) | $30.0m | ($17.0m) | — | |
| Cash, cash equivalents and restricted cash, beginning of period | $70.0m | $29.0m | $98.0m | $5.0m | $35.0m | $18.0m | — | |
| Effect of exchange rates on cash, cash equivalents and restricted cash | $1.0m | $0 | ($2.0m) | $1.0m | ($2.0m) | $2.0m | — | |
| Additional Supplementary Disclosures | ||||||||
| Additional Supplementary Disclosures | ||||||||
| Deemed non-pro rata distribution | — | — | $0 | $0 | $216.0m | $0 | — | |
| Business acquisition, net of cash acquired | — | — | $0 | $0 | ($1.0b) | ($10.0m) | — | |
| Payment for equity issuance costs | — | — | $0 | $0 | ($30.0m) | ($1.0m) | — | |
| Cash paid for income taxes, net | $2.0m | $5.0m | $3.0m | $27.0m | $4.0m | $7.0m | — | |
| Cash paid for interest, net | — | $0 | $0 | $32.0m | $27.0m | $32.0m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.